Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-12

FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Terbinafine hydrochloride from Bionpharma Inc., approving a generic antifungal product under the ANDA program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Terbinafine hydrochloride (Terbinafine hydrochloride)

Snippet

SUPPL AP for TERBINAFINE HYDROCHLORIDE (TERBINAFINE HYDROCHLORIDE)